How Long Do Hot Flashes Really Last?

Ashley Harwyn, PA-C  |  A4M Board Certified  |  August 21, 2026  |  11 min read

Longer than you were probably told

If you were told hot flashes last a year or two, that is not what the best long-term data shows. The Study of Women's Health Across the Nation, usually shortened to SWAN, is a multiracial and multiethnic observational study that followed women through the menopause transition rather than asking them to remember afterward. Among 1,449 women who reported frequent symptoms, meaning six or more days in the previous two weeks, the median total duration was 7.4 years.^[1]

Median means half of those women had symptoms for longer than 7.4 years. This is not a worst case. It is the middle.

There is a second number that matters just as much and is almost never mentioned. Among the 881 women in the study who had an observable final menstrual period, symptoms persisted for a median of 4.5 years after that period.^[1] The end of your cycles is not the end of your symptoms, and expecting it to be sets you up to feel like something has gone wrong when nothing has.

When your symptoms started predicts how long they last

This is the finding with the most practical value, and it runs opposite to what most women assume. Starting early does not mean getting it over with early. It predicts a longer course.

Women who were premenopausal or early perimenopausal when frequent symptoms first appeared had the longest total duration, a median of more than 11.8 years. Women who were already postmenopausal when symptoms began had the shortest, a median of 3.4 years.^[1]

That is a gap of roughly eight and a half years between two groups of women who might describe their symptoms in identical words. The difference is not severity. It is timing.

The study also found meaningful variation by race and ethnicity, with African American women reporting the longest total duration at a median of 10.1 years, and Japanese and Chinese women the shortest at 4.8 and 5.4 years.^[1] Averages describe populations, not the woman in front of me, but they are worth knowing when someone has been told her experience is unusual.

A symptom that lasts a decade is a different decision than one that lasts a year

Women are routinely encouraged to wait hot flashes out. That advice is reasonable if the wait is twelve months. It is a materially different proposition if the median is 7.4 years, and longer still for women whose symptoms started early.

This matters because the calculation people are actually making is not "treat or do not treat." It is "is this worth treating for how long it is going to last." If the duration estimate in your head is wrong by a factor of five, the decision built on it is wrong too.

It also reframes what counts as a reasonable trial. The Menopause Society notes that "often a period of trial and error is required to arrive at the best dose and regimen."^[2] Spending two or three months finding the right approach looks very different against a seven year horizon than against a one year one.

The treatment window and the symptom window are not the same length

Here is the tension almost nobody explains. There is a window in which the evidence most clearly favors systemic hormone therapy, and it is defined by your age and how long it has been since menopause, not by how you feel.

A January 2026 editorial in American Family Physician puts it directly: "The benefits of systemic hormone therapy for the treatment of vasomotor symptoms outweigh the risks in women younger than 60 years or within 10 years of menopause onset, provided they have no contraindications."^[3] The Menopause Society frames it the same way, describing hormone therapy as helping to control moderate to severe symptoms "when initiated within 10 years of onset of menopause or under age 60 years."^[2]

Now hold that against the duration data. A woman whose frequent symptoms began before her final period has a median duration of more than 11.8 years. The favorable initiation window is ten years. Those two numbers do not line up, and the women most affected are the ones who started earliest, which is to say the ones with the longest road ahead.

The practical consequence is that waiting has a cost that is rarely named. Deferring the conversation does not pause the clock on the window. It spends it.

What the numbers actually are, in absolute terms

Most people encounter hormone therapy risk as a percentage increase, which is close to useless for making a decision. Absolute numbers are more honest.

The same American Family Physician editorial reports that among women aged 50 to 69, roughly 59 out of 1,000 will develop breast cancer without hormone therapy. With five years of estrogen alone that figure is reported as 69 per 1,000, and with combined therapy 79 per 1,000.^[3] On the other side of the ledger, the authors note a 20% to 34% improvement in bone fracture prevention when therapy is started before age 60 or within 10 years of menopause onset.^[3]

Those are real numbers with real weight on both sides, and they are the kind of thing that should be discussed against your own history rather than a population average. What they are not is a reason to avoid the conversation.

Separately, the labeling has changed. In February 2026 the FDA approved labeling changes removing risk statements about cardiovascular disease, breast cancer and probable dementia from the boxed warning across four categories of menopausal hormone therapy.^[4] We covered what that change does and does not mean in our piece on the removal of the HRT black box warning.

Where to start, in Charleston or Mount Pleasant

If you take one thing from the data, make it this: note when your symptoms started, not just how bad they are. It is the single most informative thing you can bring to an appointment, and it is the thing least likely to be asked.

Three conversations come up most often, and they are genuinely different from one another:

Solcara Health sees patients in Mount Pleasant and at The Longevity Club in downtown Charleston. If you have been waiting this out on the assumption that it would pass quickly, it is worth finding out where you actually sit. Call 843-981-0870 or book an appointment.

Questions women actually ask

Ashley Harwyn, PA-C A4M Board Certified · Founder, Solcara Health Online

Tap a question to ask

About the author

Ashley Harwyn, PA-C

Founder, Solcara Health · Board Certified in Anti-Aging and Functional Medicine (A4M)

Ashley has practiced medicine for more than fifteen years. Her path into it began at home, with a family member born with a congenital heart defect and a childhood spent watching how much the quality of a clinician's attention could change the shape of a life. She has since practiced across a range of settings, including medical mission work in Uganda, before founding Solcara to build the kind of practice she kept wishing existed, one that treats women as whole people and tells them the truth about what the evidence does and does not support.

Full bio →

Note when it started.

Hot flashes and night sweats are not a short detour for most women. The median is 7.4 years, they commonly persist for years past the final period, and the women whose symptoms began earliest face the longest course of all.

None of that means you have to treat them. It means the decision deserves to be made against the real timeline rather than an imagined one, inside a window that is quietly spending itself while you wait.